Wuxi Biologics 00000083 Stock Revenue

1FW2 Stock  EUR 1.89  0.05  2.72%   
WUXI BIOLOGICS 00000083 fundamentals help investors to digest information that contributes to WUXI BIOLOGICS-000000's financial success or failures. It also enables traders to predict the movement of WUXI Stock. The fundamental analysis module provides a way to measure WUXI BIOLOGICS-000000's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WUXI BIOLOGICS-000000 stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

WUXI BIOLOGICS 00000083 Company Revenue Analysis

WUXI BIOLOGICS-000000's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current WUXI BIOLOGICS-000000 Revenue

    
  13.09 B  
Most of WUXI BIOLOGICS-000000's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WUXI BIOLOGICS 00000083 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition
Based on the latest financial disclosure, WUXI BIOLOGICS 00000083 reported 13.09 B of revenue. This is much higher than that of the sector and significantly higher than that of the Revenue industry. The revenue for all Germany stocks is notably lower than that of the firm.

WUXI Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WUXI BIOLOGICS-000000's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WUXI BIOLOGICS-000000 could also be used in its relative valuation, which is a method of valuing WUXI BIOLOGICS-000000 by comparing valuation metrics of similar companies.
WUXI BIOLOGICS is currently under evaluation in revenue category among its peers.

WUXI Fundamentals

About WUXI BIOLOGICS-000000 Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze WUXI BIOLOGICS 00000083's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WUXI BIOLOGICS-000000 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WUXI BIOLOGICS 00000083 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in WUXI Stock

WUXI BIOLOGICS-000000 financial ratios help investors to determine whether WUXI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WUXI with respect to the benefits of owning WUXI BIOLOGICS-000000 security.